A new method of evaluating antitumor activity from measured tumor volumes

Contemporary Clinical Trials

Volumn 27, Issue 3, 2006, Pages 269-273

  Liang, Hua ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Curve comparison; Informative dropout; Tumor response; Tumor xenograft models

Indexed keywords

IRINOTECAN; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MOUSE; NONHUMAN; RHABDOMYOSARCOMA; TREATMENT OUTCOME; TUMOR VOLUME; XENOGRAFT;

ANTINEOPLASTIC AGENTS; CARCINOMA; DATA INTERPRETATION, STATISTICAL; MICE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33646189914     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2005.11.004     Document Type: Article

References (6)

1. James K., Eisenhauer E., Christian M., et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91 (1999) 523-528
2. 6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models. Clin Cancer Res 6 (2000) 4110-4118
3. Ruppert D., Wand M.P., and Carroll R.J. Semiparametric regression (2003), Cambridge University Press, Cambridge
4. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
5. Pinheiro J.C., and Bates D.M. Mixed-effects models in S and S-PLUS (2000), Springer, New York
6. Young S.G., and Bowman A.W. Nonparametric analysis of covariance. Biometrics 51 (1995) 920-931